Introduction {#s1}
============

Mucosal secretions provide a barrier against invading pathogens and microorganisms. In the case of HIV-1, heterosexual intercourse is the main route of new infections [@pone.0079505-UNAIDS1], making the mucosa of the female genital tract (FGT) the first site of contact for male to female HIV-1 transmission. This mucosal surface is complex, and contains an abundance of soluble innate immune factors that are important for HIV-1 acquisition. Such factors include RANTES [@pone.0079505-Cocchi1] MIPα, MIPβ, SLPI [@pone.0079505-McNeely1], Elafin [@pone.0079505-Iqbal1], [@pone.0079505-Ghosh1], LL-37 [@pone.0079505-Levinson1], α/β-defensins [@pone.0079505-QuinonesMateu1], [@pone.0079505-Tanabe1], Lysozyme, Lactoferrin, Calprotectin, Histone H2A [@pone.0079505-Cole1], Cystatins, Serpins [@pone.0079505-Shapiro1] as well as many other anti-proteases [@pone.0079505-Burgener1]. The composition and balance of these factors may influence susceptibility to HIV-1, as shown in studies of HIV-exposed seronegative (HESN) individuals and individuals who succumb to infection [@pone.0079505-Iqbal1], [@pone.0079505-Burgener1]--[@pone.0079505-Sokal1]. These factors may have an impact on local viral replication, establishing the viral load set point and the rate of disease progression [@pone.0079505-Borrow1]. Also, follow-up studies to determine the correlates of protection in HIV vaccines that have shown promise such as the Thai RV144 trial [@pone.0079505-RerksNgarm1] have emphasized the importance of mucosal immune responses in reduced acquisition [@pone.0079505-RerksNgarm2]. Therefore, it is critical that these factors are properly measured to understand early events in HIV pathogenesis and transmission.

Recent clinical trials have indicated that increased immune activation in the FGT has been attributed to increased risk of HIV-infection. The importance of mucosal inflammation was exemplified by the failure of the detergent microbicide, nonoxynol-9, which increased HIV-infection risk and was associated with an increase in inflammation status in the FGT [@pone.0079505-Klasse1]. Furthermore, the lack of efficacy in the Centre for AIDS Programme of Research in South Africa (CAPRISA-004) microbicide trial may also have been attributed to increased baseline immune activation and pro-inflammatory cytokine production [@pone.0079505-Sokal1], [@pone.0079505-Naranbhai1]. However, as the biological determinants of FGT inflammation and the immune pathways important for HIV-susceptibility have not yet been defined, defining techniques and protocols to efficiently and accurately monitor a broad range of factors involved with inflammation and immune activation in the mucosal compartment will be essential for future clinical trials and the development of future intervention technologies.

The most commonly used techniques to sample the FGT mucosa involve the use of cervicovaginal lavages and/or Weck-Cel cervical sponges, which are largely standardised, inexpensive and minimally invasive [@pone.0079505-Cummins1]--[@pone.0079505-Keller1]. Each method collects secretions from different compartments of the FGT. Cervicovaginal lavages are designed to collect secretions primarily from the lower FGT, which includes the ectocervix and the vaginal vault, and Weck-Cel cervical sponges are designed to collect secretions primarily from the upper FGT, which includes the endocervix and the endometrium. However, it is unknown which technique and/or site sampled is most informative, and most relevant with respect to inflammation and the collection of immune factors. Although previous studies examining sampling techniques have noted some differences between the methods [@pone.0079505-Dezzutti1], these have been limited to a small list of pre-defined immune factors such as Secretory leukocyte peptidase inhibitor (SLPI), Human neutrophil peptides (HNP) 1--3, and Lactoferrin, despite the need to measure many other mucosal factors important in HIV-1 susceptibility and inflammation. Therefore, a comprehensive examination is warranted to better evaluate these collection techniques and the sites primarily sampled by each.

This study uses an unbiased systems biology proteomics approach via tandem mass spectrometry to compare FGT secretions using different collection methods to determine the qualitative and quantitative differences in the captured immune factors. Proteomics confers advantages to other methods as it can provide a global view of biological factors in a given sample and has been effective in monitoring the often difficult to measure, mucosal immune responses [@pone.0079505-Burgener1], [@pone.0079505-Burgener2], [@pone.0079505-Burgener3], [@pone.0079505-Burgener4]. The mucosal secretions collected by paired cervicovaginal lavages (CVL) and Weck-Cel cervical sponges (CER) were compared from 10 healthy women. In this study, we show considerable differences in both the number and abundance of mucosal factors identified in either collection method due to both the site of collection and sampling technique.

Materials and Methods {#s2}
=====================

Ethics Statement & Study Population {#s2a}
-----------------------------------

Study participants were women at low risk for HIV acquisition. To participate they had to meet the following criteria: never used crack, never exchanged sex for money, drugs or shelter, no more than one sexual partner in the last 6 months, no more than 5 sexual partners in the last 5 years, and no history of sexually transmitted infections. Study participation required written, informed consent, and was approved by the human subjects committee of the University of Illinois at Chicago. All of the participants underwent testing for Bacterial vaginosis, *Trichomonas vaginitis*, *Neisseria gonorrhoeae,* and *Chlamydia trachomatis* at the time of collection. Samples positive for any of these tests were excluded from the study. Participants included in this study were between the ages of 18 to 27 and were not on any form of hormonal contraception. Of the ten individuals included in this study, 8 were in their luteal phase and 2 were in their follicular phase of the menstrual cycle, and 2 out of the 10 had vaginal sex within 24 hours of sample collection. These factors should not confound the data obtained from this study as both CVL and CER samples were collected from the same individual at the same time. Any effect of these factors will be represented equally in sampling techniques.

Cervicovaginal Lavage (CVL) and Weck-Cel Cervical Sponge (CER) Sample Collection {#s2b}
--------------------------------------------------------------------------------

For all participants, a speculum was inserted into the vagina and the cervix was located. Four cotton tipped brushes were used to swab the posterior, lateral, frontal and ectocervical areas of the FGT for standard sexually transmitted infection testing. Next, a Weck-Cel cervical sponge was inserted into the cervical os and allowed to sit for one minute to allow for the collection of secreted factors from the upper FGT, the endocervix and the endometrium. The Weck cells were weighed in spin-x tubes before collection and after collection to determine the volume collected. The volume eluted from each sponge was ∼100--200 µL. After the sponge's removal, the cervicovaginal lavage sample was obtained by washing 10 cc of normal saline over the vaginal vault and ectocervix. The saline lavage solution was then redrawn using the same syringe of which it was instilled. All samples were immediately stored on ice and subsequently frozen at −80°C within 1 hour of sample collection.

Protein Digestion and Preparation for MS Analysis {#s2c}
-------------------------------------------------

CVL and CER sample protein content was measured by standard BCA protein assay (Novagen). One hundred micrograms from ten CVL samples and ten matching CER samples obtained from the same individual were each individually denatured with urea exchange buffer (8 M Urea GE HealthCare, 50 mM HEPES Sigma, pH 8.0) for 20 minutes at room temperature placed into Nanosep filter cartridges (10 kDa). After centrifugation samples were treated with 25 mM dithiothreitol (Sigma) for 20 minutes, then 50 mM iodoacetamide (Sigma) for 20 minutes, and washed with 50 mM HEPES buffer. Trypsin (Promega) was added (2 µg/100 µg protein) and incubated at 37°C overnight in the cartridge. Peptides were eluted off the filter with 50 mM HEPES, and were dried via vacuum centrifugation. The samples were then cleaned of salts and detergents by reversed-phase liquid chromatography (high pH RP, Agilent 1200 series micro-flow pump, Water XBridge column) using a step-function gradient such that all peptides elute into a single fraction for each sample. The fractions were then dried via vacuum centrifugation and kept at −80°C until analyzed by mass spectrometry.

Mass Spectrometry Analysis {#s2d}
--------------------------

The same amount of total protein from each sample was then prepared for label-free tandem mass spectrometry analysis. Fractions were re-suspended in 2% acetonitrile (Fisher Scientific), 0.1% formic acid (EMD Canada) and injected into a nano-flow LC system (Easy nLC, Thermo Fisher) connected inline to a LTQ Orbitrap XL (Thermo Fisher) mass spectrometer. All spectra were processed using Mascot Distiller v2.3.2 (Matrix Science), and database searching was done with Mascot v2.3 (Matrix Science). Searches were performed against UniProtKB/SwissProt (2012-05) Human (v3.87) database. Label-free protein expression levels based on MS peak intensities were calculated using Progenesis LC-MS software (v4.0 Nonlinear Dynamics). The relative abundance ratios of these proteins were calculated by dividing each value by the average intensity across all samples. Statistical analysis of protein expression was performed by one-way analysis of variance (ANOVA). Complete details of liquid chromatography, mass spectrometry instrument settings, data generation and the complete protein expression data set can be found at our public database ([www.corefacility.ca/proteomics/data/burgener/pubs/PLOS](http://www.corefacility.ca/proteomics/data/burgener/pubs/PLOS)).

Clustering and Pathway Analysis {#s2e}
-------------------------------

Cluster analysis was performed using Cluster software, version 3.0, and data was visualized using TreeView software, version 1.1.5 (13). CVL samples and CER samples were grouped separately in Perseus, version 1.3.0.4 (Max Planck Institute of Biochemistry), and all proteins were filtered based on p-values as determined by One-way ANOVA (p\<0.05). Clustering of differentially abundant proteins was generated by unsupervised centroid linkage hierarchical clustering using Pearson correlation coefficient as the distance metric. Each main dendrogram branch specific to the enrichment of proteins based on collection method from the cluster analysis was analyzed by Ingenuity Pathway Analysis (Ingenuity Systems, [www.ingenuity.com](http://www.ingenuity.com), Mountain view, CA). The association between proteins in the dataset and the canonical pathways in the Ingenuity Pathway Knowledge base was measured as a ratio of the number of molecules from the data that maps to a pathway divided by the total number of molecules known to map the canonical pathway. A right-tailed Fisher's Exact Test (with Benjamini-Hochberg multiple testing correction) was used to calculate the p-value of the probability that the association between each protein in the dataset and canonical pathway is random. Pathways with p-values \<0.05 and at least 2 proteins selected were considered as potential pathways associated with each branch in the cluster analysis. Functional annotation of the proteins differentially expressed by either collection method was performed using DAVID Bioinformatics Resources (6.7); biological functions were determined based on gene ontologies. Graphical representation of innate factors was constructed using GraphPad Prism (5.0a, GraphPad Software) using Mann-Whitney statistical tests.

Results {#s3}
=======

Mass Spectrometry Analysis of Mucosal Proteins Identifies Large Numbers of Proteins Specific to Cervicovaginal Lavages and Endocervical Sponge Samples {#s3a}
------------------------------------------------------------------------------------------------------------------------------------------------------

An unbiased, label-free proteomics approach was used to identify and quantify proteins recovered using the two most commonly used collection methods of mucosal secretions from the FGT. To allow a direct comparison, matching CER and CVL samples were collected from 10 healthy women donors. Protein concentration varied between collection methods as CER samples had an average of 2.65 µg/µL, and CVL samples had an average of 0.63 µg/µL. Based on the determined concentrations, equal amounts of total protein from each sample was then digested, processed and individually analyzed by mass spectrometry as outlined in the [Materials and Methods](#s2){ref-type="sec"}.

A total of 385 unique proteins were identified with high confidence. The relative abundance ratios of these proteins were calculated by dividing each value by the average intensity across all samples. A complete list of proteins and their relative abundance based on sample type are available as supplemental information ([Table S1](#pone.0079505.s001){ref-type="supplementary-material"}). A Venn diagram was constructed to illustrate the overlap and the number of unique proteins identified by each method ([Figure 1](#pone-0079505-g001){ref-type="fig"}). While 213 unique proteins were identified by both sampling techniques, 111 were identified solely in the CER samples, and another 61 unique proteins were exclusive to CVL samples. Of the 213 unique proteins common to both sampling techniques, 73 were found to have roles in immune functions according to their gene ontology.

![Venn diagram of the number of unique proteins collected via either sampling technique.\
Weck-Cel cervical sponge (CER) method (111), the cervicovaginal lavage (CVL) method (61), and the number of overlapping proteins identified by both methods (213).](pone.0079505.g001){#pone-0079505-g001}

To visually map the differences in protein abundances found in common across each technique, hierarchical clustering analysis was performed on the dataset. The cluster software utilizes algorithms to calculate relatedness between study participants and between protein expression patterns, and then constructs a representative dendrogram. For example, proteins of the same family, or pathway, will group more closely together as compared to proteins from another family. Proteins that showed a differential abundance (p\<0.05 as determined by one-way ANOVA) (121) were analyzed using a correlation -- uncentered similarity metric and unsupervised centroid linkage hierarchical clustering to produce a hierarchical clustering heat map ([Figure 2](#pone-0079505-g002){ref-type="fig"}). A clear pattern emerged in the dendrogram based on the sample collection method used. For example, branch 1 (top branch) clustered 68 proteins that were overabundant in the secretions collected by the CER samples, and branch 2 (bottom branch) clustered 50 proteins that were overabundant in the secretions collected by CVL. The cluster analysis was able to clearly discriminate between sampling techniques by protein abundance, which reflects a bias in each technique's ability to capture specific protein factors, and the types of factors primarily secreted by each compartment of the FGT.

![Protein abundance patterns differentiate proteins identified and recovered by both collection methods.\
the Weck-Cel cervical sponge method (CER) and the cervicovaginal lavage method (CVL) (Proteins shown (121) were identified as differentially abundant by one-way ANOVA (p\<0.05)). Clustering of proteins was generated by unsupervised centroid linkage hierarchical clustering using the Pearson correlation coefficient as the distance metric. Protein abundance levels are shown in colour, with red indicating overabundant proteins and green indicating underabundant proteins compared to the median of all samples for either collection method.](pone.0079505.g002){#pone-0079505-g002}

Site of Collection and Sampling Technique Differentially Enriches for Specific Inflammation Pathways and Functions {#s3b}
------------------------------------------------------------------------------------------------------------------

The two branches were further analyzed using Ingenuity Pathway Analysis Software to determine the top pathways associated with the proteins identified using each collection method ([Table 1](#pone-0079505-t001){ref-type="table"}). The top two pathways associated with branch 1 (CER-enriched proteins) were immune activation pathways including the Acute Phase Response Signaling pathway with 20 out of 177 proteins of the pathway identified (p = 3.37×10−24), and the Liver X Receptor/Retinoid X Receptor (LXR/RXR) Activation pathway with 17 out of 136 protein identified (p = 8.82×10−22) in this pathway. Less significant associations were found with branch 2 (CVL-enriched proteins) which corresponded to pathways involved in innate immunity including the IL-17A in Psoriasis pathway with 2 out of 13 proteins identified (p = 5.98×10−4), and the Complement System pathway with 2 out of 35 proteins identified (p = 3.91×10−3). This indicates that pathways involved with acute phase responses; immune activation and innate immunity are differentially enriched depending on the site and collection method.

10.1371/journal.pone.0079505.t001

###### Protein pathways selectively enriched based on FGT compartment/collection method.

![](pone.0079505.t001){#pone-0079505-t001-1}

  Weck-Cel Cervical Sponge Enriched Pathways (Branch 1)                       Cervicovaginal lavage Enriched Pathways (Branch 2)                                
  -------------------------------------------------------------------------- ---------------------------------------------------- ----------------------------- -----------------
  Acute Phase Response Signaling (20/177)[\*](#nt101){ref-type="table-fn"}                     P = 3.37×10^−24^                    Role of IL-17A in Psoriasis   P = 5.98×10^−4^
  LXR/RXR Activation (17/136)                                                                  P = 8.82×10^−22^                     Complement System (2/35)     P = 3.91×10^−3^

Denotes the number of protein factors identified in the proteomic dataset out of the total number of listed proteins involved in the pathway based on the Ingenuity software platform.

The two major branches of hierarchical clustering map were then further grouped using DAVID Functional Annotation Bioinformatics MicroArray Analysis tool [@pone.0079505-Huangda1], [@pone.0079505-Huangda2], which grouped proteins based on their major biological functions according to their gene ontology ([Figure 3](#pone-0079505-g003){ref-type="fig"}). Of those proteins found to be overabundant in secretions from the upper FGT collected via CER samples, 28% had immune response functions. Similarly, but to a lesser degree, 8% of the proteins found to be overabundant in secretions primarily from the lower FGT collected via CVL samples had immune response functions. These slight functional differences can partially be attributed to the differences in unique proteins identified by each method/site. For example, specific defense response proteins found in CER samples included Beta-2-microglobulin, Haptoglobin, and Complement component C3 to name a few, whereas the specific defense response proteins identified in CVL samples differed and included proteins such as Calprotectin (S100-A8/A9), Cathepsin G, and Neutrophil defensin-1. This demonstrates that each method and site of collection collects proteins involved in overlapping immune pathways, but each is differentially enriched for specific members of these pathways. Therefore, specific protein recovery is variable based on either collection method and/or the specific compartment of the FGT from which the secretions were primarily collected.

![The biological functions of the proteins determined via hierarchical cluster analysis.\
Proteins associated with Branch 1 (i) and Branch 2 (ii) of the hierarchical cluster analysis according to their gene ontology determined via the functional annotation tool from DAVID Bioinformatics Resources.](pone.0079505.g003){#pone-0079505-g003}

Antimicrobial and Immune Mediator Expression Varies Considerably in Abundance between CVL and CER Samples {#s3c}
---------------------------------------------------------------------------------------------------------

Antimicrobial factors and other immune regulators with described involvement in mucosal immune activation were examined in greater detail due to their involvement with immune activation as well as antiviral defense. These included antimicrobial and HIV inhibitory factors such as SLPI [@pone.0079505-McNeely1], [@pone.0079505-Hirbod1], Defensins [@pone.0079505-QuinonesMateu1], [@pone.0079505-Tanabe1], Lysozyme C [@pone.0079505-Venkataraman1], Mucins [@pone.0079505-Habte1], mucosal IgA [@pone.0079505-Kaul1], [@pone.0079505-Devito1]; antibacterial factors of the S100 protein family [@pone.0079505-Morizane1], protease inhibitors such as Serpins [@pone.0079505-Shapiro1], [@pone.0079505-Munch1], [@pone.0079505-Kramer1], A2ML1 and Cystatins [@pone.0079505-Burgener1], [@pone.0079505-Venkataraman1]; and proteases such as Cathepsins [@pone.0079505-Moriuchi1].

Antimicrobial factors identified from both sites were quantified and the abundance values compared as shown in [Figure 4A](#pone-0079505-g004){ref-type="fig"}. Many of these were found to be significantly different between compartments such as Cathepsin G and Lysozyme C which were found to be overabundant in CVL as compared to CER (3-fold increase, p = 0.002 and 1.7-fold increase, p = 0.04, respectively) and Cystatin B which was found to be overabundant in CER as compared to CVL (4.4-fold increase, p = 0.01). Other potential antimicrobial factors ([Figure 4B](#pone-0079505-g004){ref-type="fig"}), such as A2ML1, Haptoglobin, and Mucin 16 were found to be differentially abundant based on sampling technique, with A2ML1 overabundant in CVL (2.7-fold increase, p = 0.004,), and Haptoglobin and Mucin-16 overabundant in CER (2.5-fold increase, p = 0.04 and 2.5-fold increase, p = 0.03, respectively).

![Box plots demonstrating the abundances of various immune factors important for host defense.\
CER (endocervical sponge, red) and CVL (cervicovaginal lavage, blue). A: General antimicrobial factors, B: Potential antimicrobials, C: S100 calcium-dependent S100 family members, D: Serpin family members, E: Immunoglobulins (heavy chain variants). Significance values are shown as follows: \* = \<0.05, \*\* = \<0.005 (Mann-Whitney statistical tests).](pone.0079505.g004){#pone-0079505-g004}

Many calcium-binding proteins from the S100 Family were identified in both sites using the different collection methods used in this study ([Figure 4C](#pone-0079505-g004){ref-type="fig"}). S100 proteins are ion-binding proteins that are known to be associated with native anti-inflammatory processes [@pone.0079505-Sroussi1]--[@pone.0079505-Otsuka1]. Certain members were found to be differentially abundant based on sampling technique/compartment, such members include: S100-A4, -A6, -A8, -A9 and -P. Members S100-A4, S100-A6 and S100-P were all found to be significantly overabundant in the CER samples (5.3-fold increase, p\<0.0001, 4.8-fold increase p = 0.0007 and 2.8-fold increase, p = 0.01, respectively), and members S100-A8 and S100-A9, also known as Calprotectin were found to be significantly overabundant in CVL (3.8-fold increase, p = 0.01 and 3.6-fold increase, p = 0.01, respectively). Serpins were also recovered by both collection methods, and have recently been described as important factors in HIV-1 susceptibility [@pone.0079505-Burgener2], [@pone.0079505-Lajoie1] as they have been shown to be anti-inflammatory proteins and possess inhibitory properties against HIV-1 [@pone.0079505-Shapiro1], [@pone.0079505-Munch1]. Serpin B13 and B3 were significantly overabundant in CVL (2.9-fold increase, p = 0.01 and 3.2-fold increase, p = 0.007, respectively), and Serpin A3 was significantly overabundant in CER (3.4-fold increase, p = 0.03) as shown in [Figure 4D](#pone-0079505-g004){ref-type="fig"}. The detection of immunoglobulins was comparable by each method ([Figure 4E](#pone-0079505-g004){ref-type="fig"}), but 25% of immunoglobulins detected were only found in CER samples including IgA-2. The statistical distribution of these antimicrobial factors as well as the percentage of participants where an antimicrobial factor was reliably detected (found within +/−1 standard deviation) are shown in [Tables 2](#pone-0079505-t002){ref-type="table"}--[6](#pone-0079505-t006){ref-type="table"}. A complete list of all proteins identified and their basic statistics are available as supplemental information ([Table S2](#pone.0079505.s002){ref-type="supplementary-material"}), which can be found at our public database. ([www.corefacility.ca/proteomics/data/burgener/pubs/PLOS](http://www.corefacility.ca/proteomics/data/burgener/pubs/PLOS)).

10.1371/journal.pone.0079505.t002

###### Basic abundance variation of general antimicrobial factors collected via Weck-Cel cervical sponge and cervicovaginal lavage as determined by mass spectrometry.

![](pone.0079505.t002){#pone-0079505-t002-2}

                                        CER Protein Statistics   CVL Protein Statistics                                               
  ------------------------------------ ------------------------ ------------------------ --------- ---- --------- --------- --------- ----
  SLPI                                         346.509                  429.916           1056.26   80   155.141   179.572   534.158   80
  Cathelicidin antimicrobial peptide            11.484                   11.205           34.6626   90   12.694     16.82    56.804    90
  Cathepsin G                                   4.398                    4.813            16.4772   90   13.493     8.521    29.214    80
  Cystatin-A                                    39.053                   11.028           32.168    70   106.417   78.123    198.986   50
  Cystatin-B                                    68.922                   55.165           190.291   70   15.711    11.181     35.01    70
  Heat shock 70 kDa protein 1A/1B               17.933                   4.937            13.446    70   17.174    10.725    34.228    70
  Heat shock protein beta-1                     8.104                    4.749            14.284    60   57.748     68.91    160.24    70
  Lactotransferrin                               1830                   960.559           2873.91   60    1060     661.284   1923.95   50
  Lysozyme C                                    35.082                   42.614           141.767   90   61.211    63.987    210.252   90
  Mucin-5B                                     311.705                  215.575           626.387   60   623.761   818.538   2776.57   90
  Neutrophil defensin 1                         66.262                   55.534           156.966   80   158.861   165.313   573.889   90

10.1371/journal.pone.0079505.t003

###### Basic abundance variation of potential antimicrobial factors collected via Weck-Cel cervical sponge and cervicovaginal lavage as determined by mass spectrometry.

![](pone.0079505.t003){#pone-0079505-t003-3}

                                                    Endocervical Sponge Protein Statistics   Cervicovaginal Lavage Protein Statistics                                                 
  ------------------------------------------------ ---------------------------------------- ------------------------------------------ ---------- ---- --------- --------- ---------- ----
  WAP four-disulfide core domain protein 2                         167.994                                   179.872                    481.534    80   275.326   284.568   979.057    90
  Alpha-2-macroglobulin-like protein 1                             109.763                                    97.476                    289.359    80   294.084   163.065   477.099    70
  Deleted in malignant brain tumors 1 protein                       22.892                                    57.77                     185.9433   90   23.491    33.482    91.7083    80
  Histone H1.5                                                      2.485                                      2.5                       7.019     70    2.745     3.505     10.793    80
  Histone H2B type 1-L                                              10.643                                    15.853                     49.195    90    3.386     3.772    12.5247    90
  Mucin 1                                                            1.7                                      1.473                      4.684     80    1.202    0.9715     3.016     80
  Mucin-16                                                          3.232                                     2.293                      8.1101    70    1.281     1.242     3.8142    80
  Mucin-5AC                                                         21.357                                    30.351                     82.068    80    23.57    26.275     79.275    80
  Neutrophil gelatinase-associated **lipocalin**                   890.003                                   377.015                    1209.287   60   987.514   382.932   1196.446   60
  Haptoglobin                                                      235.945                                   172.752                    493.549    70   93.727    69.867    223.935    90

10.1371/journal.pone.0079505.t004

###### Basic abundance variation of S100 calcium-dependent family members collected via Weck-Cel cervical sponge and cervicovaginal lavage as determined by mass spectrometry.

![](pone.0079505.t004){#pone-0079505-t004-4}

                      Endocervical Sponge Protein Statistics   Cervicovaginal Lavage Protein Statistics                                               
  ------------------ ---------------------------------------- ------------------------------------------ ---------- ---- -------- -------- ---------- ----
  Protein S100-A11                    62.399                                    45.932                    141.864    70   33.758   27.81    88.6379    70
  Protein S100-A12                    18.473                                    13.393                     44.43     70   18.443   36.623   120.441    90
  Protein S100-A2                     12.852                                    20.843                     69.979    90   11.896   28.493    92.337    90
  Protein S100-A4                     16.043                                     9.08                      28.764    80   2.999    2.053     7.085     80
  Protein S100-A6                     52.863                                    35.967                    110.056    60   11.011   26.025    84.142    90
  Protein S100-A7                    767.982                                     1484                     4813.468   90    2119     5086    16503.87   90
  Protein S100-A8                    441.943                                   453.114                    1377.098   80    1662     1661    4861.71    80
  Protein S100-A9                    403.404                                   396.168                    1193.128   80    1436     1422    4097.986   80
  Protein S100-P                      42.886                                    32.266                     90.548    60   15.24    9.907     27.261    60

10.1371/journal.pone.0079505.t005

###### Basic abundance variation of serpin family members collected via Weck-Cel cervical sponge and cervicovaginal lavage as determined by mass spectrometry.

![](pone.0079505.t005){#pone-0079505-t005-5}

                Endocervical Sponge Protein Statistics   Cervicovaginal Lavage Protein Statistics                                                
  ------------ ---------------------------------------- ------------------------------------------ --------- ---- --------- --------- ---------- ----
  Serpin A3                    118.648                                   170.619                    538.164   90   34.907    30.373    104.239    90
  Serpin A1                    155.812                                    95.116                    258.713   50   90.249    43.377    142.226    70
  Serpin B1                     124.37                                    93.076                    295.518   90   179.639   96.185    304.937    70
  Serpin B10                    0.3494                                    0.5662                     1.675    70   0.8092     1.068     3.596     90
  Serpin B13                    18.211                                    14.431                    49.624    80   52.059    38.776    105.991    80
  Serpin B3                    266.189                                   175.054                    601.724   80   846.637   718.602   2130.868   80
  Serpin B4                     14.907                                    12.029                    36.131    80    22.71    18.636     60.732    80

10.1371/journal.pone.0079505.t006

###### Basic abundance variation of immunoglobulins (heavy chain variants) collected via Weck-Cel cervical sponge and cervicovaginal lavage as determined by mass spectrometry.

![](pone.0079505.t006){#pone-0079505-t006-6}

                               Endocervical Sponge Protein Statistics   Cervicovaginal Lavage Protein Statistics                                                
  --------------------------- ---------------------------------------- ------------------------------------------ --------- ---- --------- --------- ---------- ----
  Ig alpha-1 chain C region                   454.726                                   209.718                    731.341   80   375.066   175.716   458.073    40
  Ig gamma-1 chain C region                     2055                                    858.716                     2829     90    1958     925.825   3408.74    80
  Ig gamma-2 chain C region                   391.944                                   237.228                    767.211   80   339.37    224.441   670.559    70
  Ig gamma-3 chain C region                   250.382                                   155.805                    521.606   80   240.785   157.15    466.322    70
  Ig gamma-4 chain C region                    77.837                                   168.929                    549.721   90   47.038    94.003    0.047038   90
  Ig mu chain C region                         90.023                                    90.497                    323.739   90   44.541    42.229    140.992    80

Of the 37 identified antimicrobial factors examined here, seven factors (Cathepsin G, Lysozyme C, A2ML1, S100-A8, S100-A9, Serpin B3 and Serpin B13) were recovered at statistically higher amounts in CVL, and another seven different factors (Cystatin B, Mucin-16, Haptoglobin, S100-A4, S100-A6, S100-P, and Serpin A3) were recovered at statistically higher amounts in CER samples. Furthermore, twelve previously described anti-HIV factors were identified in both collection methods: SLPI, Neutrophil defensin-1, Lysozyme C, Cystatin A, DMBT1, and Mucin 5B, Lactotransferrin, Histone H1.5, Histone H2B, Cystatin B, Serpin A1, and Serpin A3. Based on these results, it is clear that the anatomical site of collection and/or method of collection can have a drastic impact on the quantity and type of mucosal factors identified particularly inflammatory and innate immune factors.

Discussion {#s4}
==========

Mucosal secretions are commonly used to evaluate the expression of innate immune factors and genital immune activation status. This form of evaluation is important for determining the safety and efficacy of HIV-1 prevention technologies such as microbicides and vaccines [@pone.0079505-Cummins1]--[@pone.0079505-Keller1]. This study is the first to employ a systems biology approach to qualify the potential factors captured using the two most common sample collection methods in the FGT. Here we found that, each site sampled by its own collection method enriches for different inflammation pathways, and each method collects site-specific abundances of antimicrobial factors including anti-HIV-1 factors.

Immune activation has been identified as a major determinant of HIV-infection risk and the monitoring of these processes will be very important for therapeutic design. These results indicated that specific inflammation pathways were enriched in CER compared to CVL, which included the acute phase response and LXR/RXR activation pathways. These two pathways play significant roles in infection and/or inflammation events. The acute phase response is a major contributor to early-stage resistance against HIV-1 infection [@pone.0079505-Kramer1] and has been shown to be specifically up regulated in HIV-resistant individuals [@pone.0079505-Burgener1]. The LXR/RXR activation pathway causes alterations in lipoprotein metabolism to provide immediate protection to the host from potential damage that may occur during the acute stage of infection. Together, these pathways are meant to provide protection against microbes using non-specific defense mechanisms of the innate immune system. This is consistent with the fact that CER samples represent more of the endocervical secretions, and these soluble mediators may act as a barrier to prevent the invasion of pathogenic organisms into the relatively sterile environment of the uterus. In contrast, the proteins found to be significantly overabundant in CVL were involved in pathways related to the innate immune response. The top two enriched pathways were the role of IL-17A in psoriasis pathway and the complement system pathway. IL-17A plays an essential role in inducing an epithelially-derived antimicrobial response against extracellular pathogens [@pone.0079505-Pappu1]. It has been shown to increase the expression of skin derived antimicrobial peptides including β-defensins, Psoriasin (S100A7) and Calprotectin (S100A8/A9) in keratinocytes [@pone.0079505-Pappu1]. The complement system pathway, a well-known and understood component of the innate immune system, involves a cascade of enzyme activations that bridge the innate and acquired immune systems [@pone.0079505-Rodriguez1], [@pone.0079505-Ricklin1]. This is consistent with the fact that CVL's represent more proteins from the vaginal vault, which is in constant contact with commensal bacteria and requires these responses to maintain a healthy mucosal barrier. Clearly these collection methods impose a bias to enriched inflammation pathways as they sample specific compartments differentially. This adds yet another layer to the rationale that it is critical to sample both the upper and the lower compartments of the FGT to provide the most comprehensive representation of inflammation responses especially when evaluating mucosal therapeutics.

This proteomic study identified many factors with known HIV inhibitory properties in different mucosal secretions of the FGT, such factors include SLPI, Cystatin A & B, Lactotransferrin, Mucin 5B, Neutrophil defensin 1, Lysozyme C, DMBT1, Histones, Serpin A3 and A1, Calprotectin (S100 A8/A9), and mucosal IgA. Each of these anti-HIV factors were recovered in both CVL and CER; although abundances between compartments varied, with Neutrophil defensin-1, Lysozyme C, Calprotectin and Cystatin A found higher in CVL; Cystatin B and Serpin A3 found higher in CER; and Lactotransferrin, Histone H1.5, Histone H2B, Serpin A1, DMBT1, Mucin 5B and SLPI found in roughly equal amounts regardless of sampling site. The differences in abundances are likely demonstrating a compartmentalized difference in secreted immune function or sampling technique specificity. For example, CVL collects secretions primarily from the lower FGT which consists of the vaginal vault and ectocervix. This compartment is at the forefront of immunological defence, as it is met with the physical stress of sexual intercourse and the constant exposure to commensal microbiota and invasive pathogens [@pone.0079505-Pudney1]. Protection is conferred by a multilayered epithelium as well as numerous immune cells housed within the strata of these layers and submucosa. Conversely, CER samples are designed to collect secretions from the upper FGT, the endocervix and the endometrium. The upper FGT differs from the lower FGT, as its epithelium only consists of a single layer of columnar epithelial cells leaving it even more vulnerable to pathogens. Thus, the upper FGT has different immune mechanisms to compensate for its vulnerability [@pone.0079505-Shacklett1]. These differences have been shown through studies examining immune factor expression with the ectocervix secreting the majority of proteins involved in innate immunity such as antiproteases, complement components and antimicrobial factors, while the endometrium secretes proteins mainly involved in tissue development [@pone.0079505-Burgener4]. Interestingly, of the three tissues examined, the endometrium produced many factors, which promote HIV infectivity. This compartmentalized difference is reinforced by the findings of our study which found an overlap in the immune factors collected by CVL and those that are known to be predominant immune factors expressed in the ectocervix [@pone.0079505-Burgener4]. However, Burgener *et al*.'s study also showed specific factors such as SLPI to be highest in abundance in endocervical tissue, whereas our study did not find a significant difference in CVL versus CER. Reasons for such results may be due to: sample cross contamination between CVL and CER collection, for instance cervical sponges may also collect secretions from the lower FGT upon removal or secretions from the upper FGT may be present in the lower FGT through natural process, or it may be due to certain factors being overexpressed in the tissue itself which is not reflected in the secretions examined. This provides evidence that both sampling techniques should ideally be used when measuring mucosal immune factors.

A previous study that specifically examined sampling techniques including CVL, vaginal swabs and endocervical swabs determined that secretions collected by CVL have higher anti-*Escherichia coli* activity over swabs, and both endocervical/vaginal swabs and CVL have comparable anti-HIV-1 activity [@pone.0079505-Dezzutti1]. This antimicrobial activity found in the secretions collected by endocervical/vaginal swabs and CVL is supported by the results of this study as there were a multitude of antimicrobial factors recovered and identified via both CER and CVL collection methods. The presence of high abundance antimicrobials such as S100 A8/A9, Lysozyme C, SLPI, and Defensins in CVL likely had contributing effects to its anti-*E. coli* activity, although antimicrobial and antiviral activity was not assessed in this study. Therefore, sampling techniques may have an impact on the measured antiviral response against HIV and other FGT infections; this may have important implications for studies and trials that monitor this activity.

It should be noted that there are other non-biological considerations for each collection method. For instance, CVL samples are more dilute than CER samples, which can make detection of low abundance proteins more challenging using mass spectrometry as the detection method. However, CVL provides a large sample volume for testing, typically recovers higher total protein content (assuming a 10 mL wash), and does not require an elution step as with sponges, which could result in protein loss. CER samples are more concentrated, sample more proteins from the upper FGT, but take longer to acquire and have smaller volumes with which to work. Another caveat of our study is the collection methods themselves, as noted above there are differences between swabs and lavages. A vaginal swab would have allowed for a more accurate comparison to an endocervical swab as it would have been a more accurate representation of the lower FGT than a lavage. Yet, the primary goal of our study was to examine the most commonly used sampling techniques of the female genital tract's mucosa, particularly those that are used in clinical trials. Therefore, we chose to examine cervicovaginal lavage as it is the most highly used method to sample the mucosa of the female genital tract, followed by the endocervical sponge, therefore we felt it was more relevant to study those two collection methods.

There were some limitations to this study that warrant consideration. Although this proteomics technique was able to identify 385 unique proteins, other important immune factors such as cytokines and chemokines were not well represented in the analysis. This is likely due to their low abundance in mucosal secretions, which was below the detection threshold of the mass spectrometer. Therefore, we cannot comment on the impact of sample methodology on these factors. Further studies will also be needed to better dissociate between the type of collection method used and the site of collection to allow better localization of where specific innate factors are being secreted and from what cell types. Still, this study provides foundational information as it compares the most commonly used techniques and demonstrates that each collection method varies considerably in both types of mucosal factors collected as well as their abundances.

In summary, CER samples collected nearly twice as many unique proteins as CVL (111 vs. 61), yet each method still collected method/site-specific abundances of inflammatory pathways and antimicrobial factors. Therefore, neither the CER nor the CVL collection method is superior to the other, but together provide a more comprehensive scope of the immune mediators secreted by both the upper and lower compartments of the FGT. As it is still unclear which factors are important in immune activation of the FGT and/or HIV susceptibility, future research should be prudent to utilize both sampling techniques to obtain the greatest recovery and most accurate measurement of the biomarkers naturally produced in the FGT. This information should be taken into consideration for studies evaluating mucosal immune responses in the development of mucosal therapeutics such as microbicides and vaccines or other aspects of reproductive immunology.
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